We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$159B
AUM Growth
+$9.87B
Cap. Flow
+$6.55B
Cap. Flow %
4.11%
Top 10 Hldgs %
17.08%
Holding
8,498
New
792
Increased
3,382
Reduced
3,111
Closed
693

Sector Composition

Rank Sector Weight
1 Healthcare 6.74%
2 Financials 6.2%
3 Technology 5.53%
4 Industrials 5.36%
5 Energy 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROV icon
6226
Provident Financial
PROV
$111M
$21K ﹤0.01%
1,141
-23,936
-95% -$426K
QAT icon
6227
iShares MSCI Qatar ETF
QAT
$63.5M
$21K ﹤0.01%
1,153
+795
+222% +$15K
RICK icon
6228
RCI Hospitality Holdings
RICK
$192M
$21K ﹤0.01%
2,049
+1,822
+803% +$18.8K
RUSHB icon
6229
Rush Enterprises Class B
RUSHB
$6.04B
$21K ﹤0.01%
2,306
+2,218
+2,520% +$19.1K
SID icon
6230
Companhia Siderúrgica Nacional
SID
$1.31B
$21K ﹤0.01%
8,329
+1,954
+31% +$5.04K
DCOY
6231
Decoy Therapeutics
DCOY
$2.19M
0
TBPH icon
6232
Theravance Biopharma
TBPH
$874M
$21K ﹤0.01%
964
-451
-32% -$9.74K
TNXP icon
6233
Tonix Pharmaceuticals
TNXP
$160M
0
WB icon
6234
Weibo
WB
$2B
$21K ﹤0.01%
755
-2,401
-76% -$58.4K
CDMO
6235
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$21K ﹤0.01%
8,345
+2,394
+40% +$6.67K
SCWX
6236
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$21K ﹤0.01%
+1,459
New +$19.8K
GENE
6237
DELISTED
Genetic Technologies Ltd.
GENE
$21K ﹤0.01%
+510
New +$23.5K
MGI
6238
DELISTED
MoneyGram International, Inc. New
MGI
$21K ﹤0.01%
2,944
+1,838
+166% +$11.8K
PTNR
6239
DELISTED
Partner Communications
PTNR
$21K ﹤0.01%
4,717
+27
+0.6% +$133
JCAP
6240
DELISTED
Jernigan Capital, Inc.
JCAP
$21K ﹤0.01%
+1,502
New +$19.8K
FLAT
6241
DELISTED
iPath US Treasury Flattener ETN
FLAT
$21K ﹤0.01%
323
-380
-54% -$23.9K
SRCI
6242
DELISTED
SRC Energy Inc
SRCI
$21K ﹤0.01%
3,160
VIAB
6243
PUT
DELISTED
Viacom Inc. Class B
VIAB
$21K ﹤0.01%
500
RTEC
6244
DELISTED
Rudolph Technologies Inc
RTEC
$21K ﹤0.01%
1,355
-196
-13% -$2.79K
PLND
6245
DELISTED
VanEck Vectors Poland ETF
PLND
$21K ﹤0.01%
1,635
-550
-25% -$7.55K
CMA.WS
6246
DELISTED
Comerica Incorporated Ws
CMA.WS
$21K ﹤0.01%
1,630
+803
+97% +$12.5K
SIGM
6247
DELISTED
Sigma Designs Inc
SIGM
$21K ﹤0.01%
3,236
-1,017
-24% -$6.76K
IBLN
6248
DELISTED
Direxion iBillionaire Index ETF
IBLN
$21K ﹤0.01%
866
-901
-51% -$21.9K
PBNC
6249
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
$21K ﹤0.01%
+613
New +$21.4K
OUTR
6250
PUT
DELISTED
OUTERWALL INC
OUTR
$21K ﹤0.01%
500

Similar funds

UBS Group's Q2 2016 Portfolio in Review

As of Q2 2016, UBS Group held 8,498 positions worth $159B, up 6.6% from $149B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group deployed $6.55B of net new capital in Q2 2016, opening 792 new positions and adding to 3,382 existing holdings. Its largest new stake was ProShares Ultra VIX Short-Term Futures ETF: 2 shares worth $29M.

By sector, the portfolio is most concentrated in Healthcare at 6.7% of assets, up from 6.7% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $645M trimmed.

  • UBS Group's largest Q2 2016 buy was ProShares Ultra VIX Short-Term Futures ETF: 2 shares worth $29M.
  • UBS Group added most to Chubb in Q2 2016, an estimated $275M increase.
  • UBS Group's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $645M.
  • UBS Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $406M.
  • UBS Group's ten largest holdings make up 17% of its $159B portfolio in Q2 2016.
  • UBS Group opened 792 new positions and closed 693 in Q2 2016.
  • UBS Group's portfolio value rose 6.6% quarter-over-quarter to $159B.

Based on UBS Group's 13F filing for Q2 2016, filed 12 Aug 2016.